Eosinophilic vasculitis of aortic valve in EGPA: a life-threatening onset of disease
Open Access
- 21 May 2026
- journal article
- case report
- Published by Taylor & Francis in Journal of Asthma
- p. 1-5
Abstract
IntroductionEosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis characterized by granulomatous and eosinophil-rich inflammation affecting small-to-medium-size vessels...Keywords
This publication has 13 references indexed in Scilit:
- Relapse of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Despite Maintenance Treatment With Low‐Dose MepolizumabRespirology Case Reports, 2025
- Heterogeneity and individualized therapy for eosinophilic granulomatosis with polyangiitisTherapeutic Advances in Respiratory Disease, 2025
- Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular ImagingEuropean Heart Journal - Cardiovascular Imaging, 2022
- Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case seriesRespiratory Research, 2021
- Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic RegurgitationAmerican Journal of Case Reports, 2019
- The Innate Immune System in Chronic Cardiomyopathy: A European Society of Cardiology (Esc) Scientific Statement from the Working Group on Myocardial Function of the ESCEuropean Journal of Heart Failure, 2018
- Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitisInternational Journal of Cardiology, 2015
- The Five-Factor Score RevisitedMedicine, 2011
- Aortic regurgitation and Churg-Strauss syndromeQJM: An International Journal of Medicine, 2005
- The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)Arthritis & Rheumatism, 1990